Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06048640 · ClinicalTrials.gov registry record · NA
Effects of Dynamine Ingestion on Various Indices of Sustained Energy
A NA study of Energy, sponsored by The Center for Applied Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06048640: Completed NA study of Energy, sponsored by The Center for Applied Health Sciences.
NCT06048640 is a NA study of Energy that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 25 participants, below the 861-participant average among 7 other Energy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06048640, a NA study of Energy, has completed, sponsored by The Center for Applied Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized, placebo-controlled, double-blind, within-subject crossover trial of 25 men and women. The objective of this study is to assess the effects of Dynamine (methylliberine) supplementation on overall well-being including energy, sustained energy, mental stamina, focus, concentration, motivation to accomplish difficult tasks, drive, vigor, positive outlook, maintaining a healthy mood, feelings of well-being, and resilience to stress.
Primary Outcome
Concentration as measured by a 10 cm visual analogue scale, where higher values represent better concentration.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Dynamine (methylliberine)
Study Locations (1)
Ohio
- The Center for Applied Health Sciences - Canfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2023-07-21 |
| Phase | NA |
What the finished NCT06048640 record still lists
NCT06048640 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 861-participant average among 7 other Energy trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Energy appearing as the primary indexed condition, and to 1 intervention - of which Dynamine (methylliberine) is the first listed.
NCT06048640 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06048640 about?
NCT06048640 is a clinical study titled "Effects of Dynamine Ingestion on Various Indices of Sustained Energy". This study is a randomized, placebo-controlled, double-blind, within-subject crossover trial of 25 men and women. The objective of this study is to assess the effects of Dynamine (methylliberine) supplementation on overall well-being including energy, sustained energy, mental stamina, focus, concent...
What is the current status of trial NCT06048640?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-09-30. Estimated completion is 2023-07-21.
What conditions does trial NCT06048640 study?
This clinical trial studies the following conditions: Energy.
What interventions are being tested in trial NCT06048640?
The interventions under investigation include: Dynamine (methylliberine) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06048640?
This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06048640 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Energy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels
RECRUITING · NA
-
Radicle Energy 24: A Study of Health and Wellness Products on Fatigue and Related Health Outcomes
COMPLETED · NA
-
Evaluating the Effects of Snack Products on Energy
COMPLETED · NA
-
The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition
COMPLETED · NA
-
Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus
COMPLETED · NA
-
Alii Supplement Study
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI